Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Oncothyreon Breast Cancer Drug Exits ASCO '15 With Good Buzz
Oncothyreon Breast Cancer Drug Exits ASCO '15 With Good Buzz
Oncothyreon Breast Cancer Drug Exits ASCO '15 With Good Buzz
Submitted by
admin
on June 1, 2015 - 9:43am
Source:
TheStreet.com
News Tags:
Oncothyreon
breast cancer
ASCO
ONT-380
HER2-positive metastatic breast cancer
Headline:
Oncothyreon Breast Cancer Drug Exits ASCO '15 With Good Buzz
Do Not Allow Advertisers to Use My Personal information
